STRONGBRIDGE BIOPHARMA plc Financing Cash Flow
STRONGBRIDGE BIOPHARMA plc reported Financing Cash Flow of -$518.00 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2021-08-05
- STRONGBRIDGE BIOPHARMA plc net cash provided by (used in) financing activities for the quarter ending 2021-06-30 was -$297.00K, a 103.23% decline year-over-year.
- STRONGBRIDGE BIOPHARMA plc net cash provided by (used in) financing activities for the quarter ending 2021-03-31 was -$221.00K.
- STRONGBRIDGE BIOPHARMA plc net cash provided by (used in) financing activities for the quarter ending 2020-12-31 was $10.73M.
- STRONGBRIDGE BIOPHARMA plc net cash provided by (used in) financing activities for the quarter ending 2020-09-30 was $27.65M.
- STRONGBRIDGE BIOPHARMA plc net cash provided by (used in) financing activities for fiscal 2020 was $47.51M, a 54511.49% increase from fiscal 2019.
- STRONGBRIDGE BIOPHARMA plc net cash provided by (used in) financing activities for fiscal 2019 was $87.00K, a 99.43% decline from fiscal 2018.
- STRONGBRIDGE BIOPHARMA plc net cash provided by (used in) financing activities for fiscal 2018 was $15.23M, a 65.00% decline from fiscal 2017.
- STRONGBRIDGE BIOPHARMA plc net cash provided by (used in) financing activities for fiscal 2017 was $43.51M, a 13.54% decline from fiscal 2016.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2021-06-30 | -$297.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$518.00K 10-Q · filed 2021-08-05 | $10.21M derived: sum of 3 quarters · filed 2021-08-05 | $37.86M derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | -$221.00K 10-Q · filed 2021-05-12 | $10.51M derived: sum of 2 quarters · filed 2021-05-12 | $38.16M derived: sum of 3 quarters · filed 2021-05-12 | $47.36M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-12-31 | $10.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $38.38M derived: sum of 2 quarters · filed 2021-03-03 | $47.58M derived: sum of 3 quarters · filed 2021-08-05 | $47.51M 10-K · filed 2021-03-03 |
| 2020-09-30 | $27.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $36.85M derived: sum of 2 quarters · filed 2021-08-05 | $36.78M 10-Q · filed 2020-10-29 | $36.78M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-06-30 | $9.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $9.13M 10-Q · filed 2021-08-05 | $9.13M derived: sum of 3 quarters · filed 2021-08-05 | $9.10M derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | -$68.00K 10-Q · filed 2021-05-12 | -$68.00K derived: sum of 2 quarters · filed 2021-05-12 | -$102.00K derived: sum of 3 quarters · filed 2021-05-12 | -$120.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | -$34.00K derived: sum of 2 quarters · filed 2021-03-03 | -$52.00K derived: sum of 3 quarters · filed 2021-03-03 | $87.00K 10-K · filed 2021-03-03 |
| 2019-09-30 | -$34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$52.00K derived: sum of 2 quarters · filed 2020-10-29 | $87.00K 10-Q · filed 2020-10-29 | -$71.39M derived: sum of 4 quarters · filed 2021-03-03 |
| 2019-06-30 | -$18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $121.00K 10-Q · filed 2020-08-04 | -$71.36M derived: sum of 3 quarters · filed 2021-03-03 | -$70.17M derived: sum of 4 quarters · filed 2021-03-03 |
| 2019-03-31 | $139.00K 10-Q · filed 2020-05-06 | -$71.34M derived: sum of 2 quarters · filed 2021-03-03 | -$70.15M derived: sum of 3 quarters · filed 2021-03-03 | -$62.20M derived: sum of 4 quarters · filed 2021-03-03 |
| 2018-12-31 | -$71.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | -$70.29M derived: sum of 2 quarters · filed 2021-03-03 | -$62.34M derived: sum of 3 quarters · filed 2021-03-03 | $15.23M 10-K · filed 2021-03-03 |
| 2018-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $9.13M derived: sum of 2 quarters · filed 2019-11-07 | $86.70M 10-Q · filed 2019-11-07 | $110.73M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $7.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $85.52M 10-Q · filed 2019-07-31 | $109.55M derived: sum of 3 quarters · filed 2020-02-28 | $129.18M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $77.57M 10-Q · filed 2019-05-01 | $101.60M derived: sum of 2 quarters · filed 2020-02-28 | $121.23M derived: sum of 3 quarters · filed 2020-02-28 | $121.23M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $24.03M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $43.66M derived: sum of 2 quarters · filed 2020-02-28 | $43.66M derived: sum of 3 quarters · filed 2020-02-28 | $43.51M 10-K · filed 2020-02-28 |
| 2017-09-30 | $19.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $19.63M derived: sum of 2 quarters · filed 2018-10-31 | $19.48M 10-Q · filed 2018-10-31 | $71.21M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$150.00K 10-Q · filed 2018-08-08 | $51.58M derived: sum of 3 quarters · filed 2019-02-27 | |
| 2017-03-31 | -$150.00K 10-Q · filed 2018-05-10 | $51.58M derived: sum of 2 quarters · filed 2019-02-27 | ||
| 2016-12-31 | $51.73M derived: 10-K 12 month − 6-K 9 month · filed 2019-02-27 | $50.32M 10-K · filed 2019-02-27 | ||
| 2016-09-30 | -$1.41M 6-K · filed 2017-11-14 | |||
| 2015-12-31 | $19.06M derived: 10-K 12 month − 6-K 9 month · filed 2018-03-12 | $19.11M derived: sum of 2 quarters · filed 2018-03-12 | $51.65M derived: sum of 3 quarters · filed 2018-03-12 | $77.40M 10-K · filed 2018-03-12 |
| 2015-09-30 | $45.00K derived: 6-K 9 month − 6-K 6 month · filed 2016-12-30 | $32.59M derived: sum of 2 quarters · filed 2016-12-30 | $58.34M 6-K · filed 2016-12-30 | |
| 2015-06-30 | $32.54M derived: 6-K 6 month − 6-K 3 month · filed 2016-12-30 | $58.30M 6-K · filed 2016-12-30 | ||
| 2015-03-31 | $25.75M 6-K · filed 2016-05-17 | |||
| 2014-12-31 | $10.19M 20-F · filed 2017-04-04 | |||
| 2013-12-31 | $14.92M 20-F · filed 2016-03-24 |